Article Details
Retrieved on: 2024-01-05 20:20:32
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Sana Biotechnology, Inc. phase 1 study results for SC291 and SC262 offer hope for patients with B-cell lymphomas and other disease.
Article found on: seekingalpha.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here